No |
Date |
Speaker |
teacher |
Journal |
Score |
Publish |
Title |
1 |
10/06 |
|
|
Nature communications |
17.694 |
2022/9/19 |
Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells |
2 |
10/06 |
|
|
Nature communications |
17.694 |
2022/09/07 |
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer |
3 |
10/13 |
|
|
Nature communications |
17.694 |
2023/03/18 |
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma |
4 |
10/13 |
|
|
Nature communications |
17.694 |
2023/04/20 |
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma |
5 |
10/27 |
|
|
Journal of Hepatology |
25.7 |
2022/10/26 |
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment |
6 |
10/27 |
|
|
Nature communications |
17.694 |
2023/01/23 |
Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia |
7 |
11/3 |
|
|
BRAIN BEHAVIOR AND IMMUNITY |
15.1 |
2022/12/28 |
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis |
11/3 |
|
|
Nature communications |
17.694 |
2022/12/27 |
PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression |
|
11/17 |
|
|
Nature communications |
17.694 |
2023/05/19 |
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer |
|
11/17 |
|
|
Nature communications |
17.694 |
2022/08/04 |
Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase |
|
11 |
11/24 |
|
|
Advanced Science |
15.1 |
2023/05/11 |
GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer |
12 |
11/24 |
|
|
Nature communications |
17.694 |
2023/05/31 |
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer |
13 |
12/1 |
|
|
Nature communications |
16.6 |
2023/01/19 |
Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis |
12/1 |
|
|
Molecular Cell |
16.0 |
2022/11/03 |
Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation |
|
15 |
12/8 |
|
|
Nature communications |
17.694 |
2023/8/17 |
C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption |
16 |
12/8 |
|
|
Autophagy |
13.3 |
2022/07/11 |
Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis |
17 |
12/15 |
|
|
Nature communications |
17.694 |
2023/05/08 |
Antibody blockade of Jagged1 attenuates choroidal neovascularization |
18 |
12/15 |
|
|
Nature communications |
17.694 |
2023/03/02 |
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19 |
19 |
12/22 |
|
|
Molecular Cell |
16.0 |
2022/6/6 |
MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts |
12/22 |
|
|
The EMBO Journal |
11.4 |
2023/3/27 |
TFEB-dependent lysosome biogenesis is required for senescence |